on June 16, 2026
From Prostate Physiology to Integrative Medicine: A New Support Paradigm
Prostate and urinary tract issues represent one of the most common conditions in adult and elderly men. Lower urinary tract symptoms (LUTS), benign prostatic hyperplasia (BPH), chronic prostatitis, chronic pelvic pain, and certain conditions of prostate fragility can significantly affect quality of life.
In recent years, interest has grown in integrative approaches that combine conventional medicine, diet, lifestyle, and phytotherapy based on biological evidence.
Among the proposals developed in this field is the protocol devised by Dr. Gabriele Mammana, former head of the Urology Department at Macerata Hospital, based on the use of natural substances selected for their potential role in supporting prostate and urinary tract well-being.
It is important to emphasize that phytotherapy does not replace urological diagnosis nor the medical or oncological treatments indicated by guidelines, but can represent a complementary support within a personalized path.
When to Think About Prostate Health
Major scientific societies suggest actively addressing the issue of male urinary disorders starting at age 50, or earlier in the presence of a family history.
Some symptoms deserve clinical attention:
getting up frequently during the night to urinate
urinary urgency
difficulty emptying the bladder
reduced urinary stream
feeling of incomplete emptying
pelvic pain or perineal discomfort
The presence of one or more symptoms does not equate to a diagnosis of prostate pathology, but represents a reason for medical follow-up.
The Role of Phytotherapy in Prostate Issues
Modern phytotherapeutic research focuses mainly on four biological mechanisms:
modulation of chronic inflammation
control of oxidative stress
support of pelvic microcirculation
regulation of cellular proliferative signals
The evidence is more solid in functional and chronic inflammatory forms compared to oncological prevention.
The Most Studied Natural Substances
Serenoa repens
Among the most studied plant extracts for BPH.
It acts through multiple mechanisms including androgen metabolism modulation, anti-inflammatory activity, and reduction of tissue edema.
Meta-analyses show heterogeneous results, with possible benefit especially in mild-to-moderate urinary symptoms.
Pygeum africanum
Pygeum bark extract has been associated in clinical studies with improvement in pollakiuria, nocturia, and urinary flow quality.
Anti-edema effects and support of bladder contractility have been described.
Nettle (Urtica dioica)
Nettle roots are traditionally used for male urinary well-being.
Experimental studies suggest anti-inflammatory, anti-edema effects, and modulation of prostate cell proliferation.
Commission E, ESCOP, and WHO recognize its traditional use in supporting urinary disorders associated with BPH.
Epilobium
Preclinical literature describes antioxidant, antiproliferative, and anti-inflammatory properties.
The European monograph reports its traditional use for the relief of lower urinary tract symptoms.
Passionflower and Eleuthero
In chronic pelvic pain syndromes and forms where stress and muscle tension contribute to symptomatology, substances with adaptogenic or relaxing action can represent a complementary support.
Nutraceuticals and Prevention: What the Literature Says
Green Tea and Catechins
Green tea epigallocatechins are among the most studied natural compounds.
Preliminary clinical studies have suggested a possible reduction in the progression of high-risk prostate lesions, probably through antioxidant activity and regulation of cell proliferation.
Lycopene
The tomato carotenoid has been associated in meta-analyses with a reduction in the risk of prostate cancer, especially in populations with higher dietary consumption.
Resveratrol and Pterostilbene
They are polyphenols with biological activities observed mainly in experimental studies.
The studied mechanisms include NF-kB modulation, apoptosis, and control of oxidative stress.
To date, there is insufficient evidence to consider them antitumor treatments.
Curcumin
Cellular and preclinical studies suggest an interaction with pathways involved in prostate proliferation, including the regulation of the androgen receptor and intracellular signals.
Clinical data in humans remain limited.
Pomegranate
Polyphenols and ellagic acid have shown antioxidant and immunomodulatory properties.
Some preliminary clinical studies have explored its role as metabolic support during oncological therapeutic paths.
Broccoli and Sulforaphane
Cruciferous vegetables represent one of the most studied food classes for their chemopreventive potential.
Sulforaphane shows epigenetic activity and modulation of enzymes involved in cell proliferation.
Urinary Tract and Recurrence Prevention: The Role of D-Mannose and Cranberry
In recurrent urinary tract infections, non-antibiotic support strategies are emerging.
D-mannose has a high affinity for the fimbriae of certain uropathogenic bacteria, hindering their adhesion to the urothelium.
Cranberry, especially rich in type A proanthocyanidins, has been studied for the reduction of infectious recurrences.
The evidence is more favorable in prevention compared to the treatment of acute infection.
Integrative Approach: Not Just Supplements
Prostate well-being requires a global view.
Regular hydration during the day contributes to urinary physiology.
Limiting highly irritating foods can reduce discomfort in predisposed subjects.
Aerobic physical activity favors pelvic microcirculation.
Regular sexual activity can contribute to the physiological drainage of prostatic secretions.
In the presence of family history or persistent symptoms, periodic urological check-ups are advisable.
Conclusions
The integration of phytotherapy, nutrition, and clinical medicine represents an area of growing interest in prostate issues.
The most studied natural substances seem to exert their effect mainly through anti-inflammatory, antioxidant, and functional support mechanisms.
However, the use of integrative protocols must be part of a personalized medical path, avoiding attributing to supplements diagnostic or therapeutic purposes proper to drugs.
Bibliography
Wilt TJ, et al. Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst Rev. 2012.
Wilt TJ, et al. Beta-sitosterols for benign prostatic hyperplasia. BJU Int. 1999.
Ishani A, et al. Pygeum africanum for benign prostatic hyperplasia. Cochrane Database Syst Rev. 2000.
Yang CS, et al. Green tea and cancer prevention. Nat Rev Cancer. 2009.
Kumar NB, et al. Green tea polyphenols in prostate cancer prevention. Cancer Prev Res. 2015.
Chen P, et al. Lycopene and Risk of Prostate Cancer. Medicine (Baltimore). 2015.
Dybkowska E, et al. Resveratrol occurrence and health effects. Rocz Panstw Zakl Hig. 2018.
Baradaran Rahimi V, et al. Ellagic acid and immunomodulation. Phytother Res. 2020.
Dashwood RH, et al. Sulforaphane and epigenetic regulation in prostate cancer. Oncogenesis. 2016.
Kranjcec B, et al. D-mannose in recurrent urinary tract infections. World J Urol. 2014.
Howell AB, et al. Cranberry proanthocyanidins and urinary tract health. Phytochemistry. 2010.
European Medicines Agency (EMA). Monographs on Epilobium and Urtica dioica.
